This is an investigational device limited by Federal (or United States) law to investigational use as directed by a healthcare provider or study doctor. It is not intended for personal use. AKL-T01 is a novel, highly immersive, digital therapeutic intervention that is deployed on mobile iOS devices which incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms. CAUTION: If using a certified personal mobile device, follow your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device. This software may cause: Dizziness, Nausea, Headache, Emotional Reaction, Aggression, or Decreased Frustration Tolerance. AKL-T01 may not be appropriate for patients with photosensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device. Consult with your healthcare provider or study doctor before use. Please see the Terms of Use below for applicable patent protection for this software. Terms of Use: https://my.akili.care/terms
